Uterine cancer is the only cancer that has seen survival rates continuously fall in the last 40 years, but research published March 4 in the British Journal of Cancer suggests that using a medication to block a protein called Galectin-3 could be a more effective treatment.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
